Safety and Efficacy of Tarlatamab in patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study | NeoGenomics Laboratories

Publication date

Mon, 09/15/2025 - 12:00

Category

Multiplex Immunofluorescence

Year

External link

https://aacrjournals.org/clincancerres/article/31/18/3854/764540/Safety-and-Eff…